Peritoneal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases
Conditions:   Unresectable Colon Cancer Peritoneal Metastases;   PMMR/Ras/BRAF Wild-type Intervention:   Drug: Serplulimab Combined With FOLFIRI and Bevacizumab Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Changxing People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2023 Category: Research Source Type: clinical trials